Clinical Trial Update: A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic evaluation comparing two nicotine patches in smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nicotine patch (nicotine patch)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Smoking | Phase 1 | Status: COMPLETED | Results posted: 2015-02-11